Actively Recruiting
Amblyopia Treatment for Children Aged 8 to 12 Years
Led by Retina Foundation of the Southwest · Updated on 2025-12-15
30
Participants Needed
1
Research Sites
181 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.
CONDITIONS
Official Title
Amblyopia Treatment for Children Aged 8 to 12 Years
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female and male children with amblyopia aged 8 to 12 years inclusive
- Amblyopic eye visual acuity of 1.0 logMar (20/32-20/200) or better
- Difference in visual acuity between eyes of 0.3 logMAR or more
- Anisometropia or strabismus corrected to less than 5 prism diopters
- Wearing glasses (if needed) for at least 8 weeks
- No longer using standard treatments for amblyopia
- Informed consent provided
You will not qualify if you...
- Prematurity greater than 8 weeks
- Coexisting ocular or systemic disease
- Developmental delay
- History of light-induced epilepsy
- Eye conditions that interfere with eye tracking, such as nystagmus, wearing rigid gas permeable contact lenses, paralysis of extra ocular muscles, or ptosis covering the pupil
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Retina Foundation of the Southwest
Dallas, Texas, United States, 75231
Actively Recruiting
Research Team
E
Eileen E Birch, PhD
CONTACT
R
Reed M Jost, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here